Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1647, Issue 1-2, 2003, Pages 48-54

  Boomsma, Frans ^a   Bhaggoe, Usha M ^a   Van Der Houwen, Angelique M B ^a   Van Den Meiracker, Anton H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion molecule; Amine oxidase; Diabetes; Human plasma; Inflammation; Vascular disease

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); SEMICARBAZIDE DERIVATIVE;

CHILD; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL LUNG DISEASE; CONGESTIVE HEART FAILURE; ENZYME ACTIVITY; HEPATITIS; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CIRRHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; VASCULAR DISEASE; BLOOD; DIABETES MELLITUS; DIAPHRAGM HERNIA; ENZYMOLOGY; REVIEW;

AMINE OXIDASE (COPPER-CONTAINING); DIABETES MELLITUS; HEART FAILURE, CONGESTIVE; HERNIA, DIAPHRAGMATIC; HUMANS; INFLAMMATION; SEMICARBAZIDES;

EID: 0038312088     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00047-5     Document Type: Conference Paper

References (40)

1. Lyles G.A. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int. J. Biochem. Cell Biol. 28:1996;259-274.
2. Boomsma F. Semicarbazide-sensitive amine oxidases: widespread occurrence and many names and faces. Neurobiology (Bp.). 8:2000;1-16.
3. Boomsma F., van Dijk J., Bhaggoe U.M., Bouhuizen A.M.B., van den Meiracker A.H. Variation in semicarbazide-sensitive amine oxidase activity in plasma and tissues of mammals. Comp. Biochem. Physiol., C. 126:2000;69-78.
4. Jalkanen S., Salmi M. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 20:2001;3893-3901.
5. Yu P.H., Zuo D.-M. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Diabetes. 42:1993;594-603.
6. Lyles G.A., Chalmers J. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem. Pharmacol. 43:1992;1409-1414.
7. Janes S.M., Mu D., Wemmer D., Smith A.J., Kaur S., Maltby D., Burlingame A.L., Klinman J.P. A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science. 248:1990;981-987.
8. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188:1998;17-27.
9. Enrique-Tarancón G., Marti L., Morin N., Lizcano J.M., Unzeta M., Sevilla L., Camps M., Palacín M., Testar X., Carpéné C., Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 273:1998;8025-8032.
10. Yu P.H., Zuo D.-M. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia. 40:1997;1243-1250.
11. Yu P.H., Deng Y.L. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis. 140:1998;357-363.
12. Grönvall J.L.E., Garpenstrand H., Oreland L., Ekblom J. Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes. Life Sci. 63:1998;759-768.
13. Boomsma F., Derkx F.H.M., van den Meiracker A.H., Man in 't Veld A.J., Schalekamp M.A.D.H. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. 88:1995;675-679.
14. van Dijk J., Boomsma F., Alberts G., Man in 't Veld A.J., Schalekamp M.A.D.H. Determination of semicarbazide-sensitive amine oxidase in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. 663:1995;43-50.
15. Lizcano J.M., Unzeta M., Tipton K.F. A spectrophotometric method for determining the oxidative deamination of methylamine by the amine oxidases. Anal. Biochem. 286:2000;75-79.
16. van Dijk J., Boomsma F. Stability of semicarbazide-sensitive amine oxidase in human blood and plasma. Clin. Chim. Acta. 270:1998;189-194.
17. Boomsma F., van den Meiracker A.H., Man in 't Veld A.J., Schalekamp M.A.D.H. Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease. Life Sci. 57:1995;1753-1759.
18. Conklin D.J., Trent M.B., Boor P.J. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and β- aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats. Toxicology. 138:1999;137-154.
19. Claud P., Padovani P., Guichard J.-P., Artur Y., Lainé R. Involvement of semicarbazide-sensitive amine oxidase in tresperimus metabolism in human and in rat. Drug Metab. Dispos. 29:2001;735-741.
20. McEwen C.M., Cohen J.D. An amine oxidase in normal human serum. J. Lab. Clin. Med. 62:1963;766-776.
21. McEwen C.M., Harrison D.C. Abnormalities of serum monoamine oxidase in chronic congestive heart failure. J. Lab. Clin. Med. 65:1965;546-559.
22. McEwen C.M., Castell D.O. Abnormalities of serum monoamine oxidase in chronic liver disease. J. Lab. Clin. Med. 70:1967;36-47.
23. Nilsson S.E., Tryding N., Tufvesson G. Serum monoamine oxidase (MAO) in diabetes mellitus and some other internal diseases. Acta Med. Scand. 184:1968;105-108.
24. Tryding N., Nilsson S.E., Tufvesson G., Berg R., Carlström S., Elmfors B., Nilsson J.E. Physiological and pathological influences on serum monoamine oxidase level. Scand. J. Clin. Lab. Invest. 23:1969;79-84.
25. Lewinsohn R. Human serum amine oxidase. Enzyme activity in severely burnt patients and in patients with cancer. Clin. Chim. Acta. 81:1977;247-256.
26. Boomsma F., van den Meiracker A.H., Winkel S., Aanstoot H.J., Batstra M.R., Man in 't Veld A.J., Bruining G.J. Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis. Diabetologia. 42:1999;233-237.
27. Garpenstrand H., Ekblom J., Backlund L.B., Oreland L., Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet. Med. 16:1999;514-521.
28. Mészáros Z., Szombathy T., Raimondi L., Karádi I., Romics L., Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism. 48:1999;113-117.
29. Boomsma F., Ekberg K., Bruining G.J. C peptide and insulin do not influence plasma semicarbazide-sensitive amine oxidase activity. Diabetologia. 44:2001;388-389.
30. Boomsma F., van Veldhuisen D.J., de Kam P.J., Man in 't Veld A.J., Mosterd A., Lie K.I., Schalekamp M.A.D.H. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33:1997;387-391.
31. Boomsma F., de Kam P.J., Tjeerdsma G., van den Meiracker A.H., van Veldhuisen D.J. Plasma semicarbazide-sensitive amine oxidase is an independent prognostic parameter for survival in congestive heart failure. Eur. Heart J. 21:2000;1859-1863.
32. B. Cost, Heart failure in the elderly, Thesis Erasmus University Rotterdam, 2000, pp. 67-82.
33. Sikkema J.M., Frankx A., Fijnheer R., Nikkels P.G.J., Bruinse H.W., Boomsma F. Semicarbazide-sensitive amine oxidase in pre-eclampsia: no relation with markers of endothelial cell activation. Clin. Chim. Acta. 324:2002;31-38.
34. Mészáros Z., Karádi I., Csányi A., Szombathy T., Romics L., Magyar K. Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur. J. Drug Metab. Pharmacokinet. 24:1999;299-302.
35. Kurkijärvi R., Adams D.H., Leino R., Möttönen T., Jalkanen S., Salmi M. Circulating form of vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J. Immunol. 161:1998;1549-1557.
36. Boomsma F., Janssen D.J., Zimmerman L.J., Van den Bosch A., Emmen E., Bruining G.J., Tibboel D. Plasma SSAO in neonates with congenital diaphragmatic hernia and with lung damage. Proceedings of the 9th International Amine Oxidase Workshop. 2000;41 Unìversìtat Autònoma de Barcelona, Barcelona.
37. Bergquist M., Garpenstrand H., Brattström D., Hesselius P., Wagenius G., Brodin O., Oreland L. SSAO and its correlation to survival in lung cancer patients. Proceedings of the 9th International Amine Oxidase Workshop. 2000;88 Unìversìtat Autònoma de Barcelona, Barcelona.
38. Brattström D., Garpenstrand H., Bergquist M., Hesselius P., Wagenius G., Brodin O., Oreland L. SSAO and its correlation to angiogenesis in lung cancer patients. Proceedings of the 9th International Amine Oxidase Workshop. 2000;89 Unìversìtat Autònoma de Barcelona, Barcelona.
39. Ekblom J., Grönvall J., Lennernäst B., Nilsson S., Garpenstrand H., Oreland L. Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer. Clin. Sci. 97:1999;111-115.
40. Baba S., Watanabe Y., Gejyo F., Arakwa M. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin. Chim. Acta. 136:1984;49-56.